Person looking at computer screen

International Developed Equity Allocation Series Fund

  • Vehicle Mutual Fund
  • Asset Class Equities

Overview

The GMO International Developed Equity Allocation Series Fund seeks to generate total return greater than that of the MSCI EAFE Index.

The philosophy that underlies all of GMO’s Asset Allocation investment strategies is the belief that, at times and in the short term, the pricing of asset classes can deviate from true intrinsic value, but mean reverts to appropriate valuation levels over the long term. Using GMO’s 7-Year Asset Class Forecasts, the Fund seeks to allocate to areas of the global equity markets we believe are most attractively valued. Our approach combines the best of GMO’s top-down Asset Allocation views and bottom-up equity research to identify mispricings at both the asset class and individual security levels. The Fund allocates to equity strategies that are actively managed by other GMO investment teams with expertise and experience in security selection within their respective markets. The Fund is allowed to invest up to 10% (at time of purchase) in emerging market equities.

Facts

Doc Table
Fund Total Assets as of 4/30/2019 $13mm USD
Benchmark MSCI EAFE

Share Class R6

Ticker Symbol GIDRX
CUSIP 380131359
NAV as of 5/20/2019 9.30
Net Expense Ratio 1 0.68
Gross Expense Ratio 2 0.69

1 Net Expense Ratio reflects the reduction of expenses from fee reimbursements. The fee reimbursements will continue until at least June 30, 2019. Elimination of this reimbursement will result in higher fees and lower performance.

2 Gross Expense Ratio is equal to the Funds Total Annual Operating Expenses set forth in the Funds most recent prospectus dated June 30, 2018.

Performance

Quarter-End as of March 31, 2019(USD, %) | GMO Int'l Developed Eqty Alloc Series R6

Table Caption
1-Year 3-Year 5-Year 10-Year ITD
International Developed Equity Allocation Series Fund -10.01 5.44 -0.29 7.65 2.75
MSCI EAFE -3.55 7.28 2.33 8.96 2.94
  • International Developed Equity Allocation Series Fund 1
  • MSCI EAFE

Inception Date: June 05, 2006

Returns shown for periods greater than one year are on an annualized basis.

If certain expenses were not reimbursed, performance would be lower. Transaction costs, if any, are paid to the fund to offset the cost of portfolio transactions to invest or raise cash.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 The inception date above refers to the inception date of the Int'l. Developed Eqty Allocation Fund. Class R6 shares were first offered on August 31, 2013. GMO Int'l Developed Eqty Alloc Series Fund is a feeder fund investing substantially all of its assets in shares of a corresponding master fund (i.e., a corresponding GMO Trust fund). Performance data quoted for GMO Int'l Developed Eqty Alloc Series Fund reflects the performance data of the corresponding GMO Trust master fund re-stated to reflect the fees and expenses associated with GMO Int'l Developed Eqty Alloc Series Fund.

Quarter-End as of March 31, 2019(USD, %) | GMO Int'l Developed Eqty Alloc Series R6

Table Caption
QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
International Developed Equity Allocation Series Fund 10.69 10.69 -10.01 5.44 -0.29 7.65 2.75
MSCI EAFE 9.98 9.98 -3.55 7.28 2.33 8.96 2.94
  • International Developed Equity Allocation Series Fund 1
  • MSCI EAFE

Inception Date: June 05, 2006

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 The inception date above refers to the inception date of the Int'l. Developed Eqty Allocation Fund. Class R6 shares were first offered on August 31, 2013. GMO Int'l Developed Eqty Alloc Series Fund is a feeder fund investing substantially all of its assets in shares of a corresponding master fund (i.e., a corresponding GMO Trust fund). Performance data quoted for GMO Int'l Developed Eqty Alloc Series Fund reflects the performance data of the corresponding GMO Trust master fund re-stated to reflect the fees and expenses associated with GMO Int'l Developed Eqty Alloc Series Fund.

Month-End as of April 30, 2019(USD, %) | GMO Int'l Developed Eqty Alloc Series R6

Table Caption
MTD QTD YTD 1-Year 3-Year 5-Year 10-Year ITD
International Developed Equity Allocation Series Fund 2.94 2.94 13.94 -7.37 5.73 -0.29 7.21 2.96
MSCI EAFE 2.81 2.81 13.07 -3.22 7.25 2.60 7.95 3.14
  • International Developed Equity Allocation Series Fund 1
  • MSCI EAFE

Inception Date: June 05, 2006

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 The inception date above refers to the inception date of the Int'l. Developed Eqty Allocation Fund. Class R6 shares were first offered on August 31, 2013. GMO Int'l Developed Eqty Alloc Series Fund is a feeder fund investing substantially all of its assets in shares of a corresponding master fund (i.e., a corresponding GMO Trust fund). Performance data quoted for GMO Int'l Developed Eqty Alloc Series Fund reflects the performance data of the corresponding GMO Trust master fund re-stated to reflect the fees and expenses associated with GMO Int'l Developed Eqty Alloc Series Fund.

Year Ending December 31 (USD, %) | GMO Int'l Developed Eqty Alloc Series R6

Calendar
International Developed Equity Allocation Series Fund MSCI EAFE
2018 -19.50 -13.79
2017 26.00 25.03
2016 3.17 1.00
2015 -6.70 -0.81
2014 -5.88 -4.90
2013 24.17 22.78
2012 17.06 17.32
2011 -9.49 -12.14
2010 10.79 7.75
2009 19.71 31.78
  • International Developed Equity Allocation Series Fund 1
  • MSCI EAFE

Inception Date: June 05, 2006

Returns shown for periods greater than one year are on an annualized basis.

Net of all fees and expenses after reimbursement by the Manager, but not transaction costs, if any. If certain expenses were not reimbursed, performance would be lower.

Performance data quoted represents past performance and is not indicative of future results. The investment return and principal value of an investment will fluctuate so that an investor's shares, when redeemed, may be worth more or less than their original cost. Current performance data may be lower or higher than the performance data provided herein.

1 The inception date above refers to the inception date of the Int'l. Developed Eqty Allocation Fund. Class R6 shares were first offered on August 31, 2013. GMO Int'l Developed Eqty Alloc Series Fund is a feeder fund investing substantially all of its assets in shares of a corresponding master fund (i.e., a corresponding GMO Trust fund). Performance data quoted for GMO Int'l Developed Eqty Alloc Series Fund reflects the performance data of the corresponding GMO Trust master fund re-stated to reflect the fees and expenses associated with GMO Int'l Developed Eqty Alloc Series Fund.

Management

Inker_Ben

Ben Inker

Head of Asset Allocation

Mr. Inker is head of GMO’s Asset Allocation team and a member of the GMO Board of Directors. He joined GMO in 1992 following the completion of his B.A. in Economics from Yale University.  In his years at GMO, Mr. Inker has served as an analyst for the Quantitative Equity and Asset Allocation teams, as a portfolio manager of several equity and asset allocation portfolios, as co-head of International Quantitative Equities, and as CIO of Quantitative Developed Equities.  He is a CFA charterholder.

Documents

Downloads

Performance
Portfolio Composition
Holdings
Download All

Commentary & Attribution

Commentary - Quarterly
Commentary - Annual
Market Review
Attribution - Monthly
Attribution - Quarterly
Attribution - YTD
Download All

Investor Information

Annual Report
Semiannual Report
NAVs and Distributions
Distribution Dates
Summary Distribution (Prior Year)
Download All

Risks

Risks associated with investing in the Fund may include those as follows. (1) Market Risk - Equities: The market price of equities may decline due to factors affecting the issuing companies, their industries, or the economy and equity markets generally. Declines in stock market prices generally are likely to reduce the net asset value of the Fund's shares. (2) Non-U.S. Investment Risk: The market prices of many non-U.S. securities fluctuate more than those of U.S. securities. Many non-U.S. markets are less stable, smaller, less liquid, and less regulated than U.S. markets, and the cost of trading in those markets often is higher than it is in U.S. markets. (3) Management and Operational Risk: The risk that GMO's investment techniques will fail to produce desired results. For a more complete discussion of these risks and others, please consult the Fund's prospectus.

Disclosures

An investor should consider the fund’s investment objectives, risks, charges and expenses before investing. This and other important information can be found in the fund’s prospectus. Read the prospectus carefully before investing. Please see prospectus above. 

Each GMO Series Trust Fund is a feeder fund investing substantially all of its assets in shares of a corresponding GMO Trust Fund (i.e., a master fund). Under the master-feeder structure, each GMO Series Trust Fund's sole portfolio holding, other than cash, is shares of the corresponding GMO Trust Fund.

The GMO Trust funds are distributed in the United States by Funds Distributor LLC. GMO and Funds Distributor LLC are not affiliated.